top
Search terms
Results 1 - 6 of 6 - ordered by :
Escardio

Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care – although a ...

Date : 28/08/2016
Escardio

Low BMI is a risk factor for CVD in hypertensive patients with diabetes, according to research presented at the ESC Congress today by Dr Takanori Nagahiro from Japan. Dr Nagahiro said: ...

Date : 03/09/2013
Escardio

The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) already published and presented during AHA 20181 randomized 8179 patients with established ...

Date : 06/05/2019
Escardio

Placement of a implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care – although a ...

Date : 28/08/2016
Escardio

Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in patients at high risk of death after ST-segment elevation myocardial infarction ...

Date : 03/09/2019
Escardio

The risk of death is highest in the first 6 months following myocardial infarction (MI).1,2 However, current ESC Guidelines recommend a delay of at least 6 weeks after MI before considering ...

Date : 04/09/2019